-
FDA grants fast-track designation to malaria drug Tafenoquine
pharmaceutical-technology
January 09, 2018
The US Food and Drug Administration (FDA) has granted fast-track designation to 60 Degrees Pharmaceuticals’ (60P) Tafenoquine for the prevention of malaria in adults.
-
Orchid Pharma gets EIR from US FDA
expressbpd
January 09, 2018
The Chennai facility was recently inspected by US FDA
-
Summary of M&As in 2017
Dopine
January 08, 2018
2018 is here. I’d like to summarize characteristics of the M&As in the pharmaceutical field of 2017.
-
The FDA Fast Tracks 60 Degrees Pharma's Malaria Drug
biospace
January 05, 2018
60 Degrees Pharma Fast Tracked for Malaria Drug
-
FDA Bestows Breakthrough Tag on Shire's Maribavir
biospace
January 05, 2018
Shire Receives FDA Breakthrough Therapy Designation for Maribavir, an Investigational Treatment for Cytomegalovirus (CMV) Infection in Transplant Patients
-
Novartis Announces 2018's Second FDA Breakthrough Tag of the Week
biospace
January 05, 2018
A Novartis drug approved as a second-line treatment for a blood disorder snagged the U.S. Food and Drug Administration’s Breakthrough Therapy Designation as a first-line defense.
-
Palatin Technologies Announces FDA Clearance of IND Application for PL-8177 for Ulcerative Colitis
biospace
January 04, 2018
Palatin Technologies announced today that the U.S. Food and Drug Administration (FDA) may continue its subcutaneous injection of PL-8177 as a potential clinical study of patients with ulcerative colitis
-
FDA Hails Novartis' Kisqali a Breakthrough
biospace
January 04, 2018
Little more than 10 months after its approval to treat some postmenopausal breast cancer patients, Novartis’ Kisqali (ribociclib) snagged Breakthrough Therapy Designation to treat a new segment of premenopausal breast cancer patients.
-
FDA approves shock wave wound healing device
pharmafile
January 03, 2018
Continuing its recent trend to promote innovative new technologies, the FDA has announced that it has approved a medical device that uses shock waves to help promote wound healing in those suffering from diabetes.
-
46 New Drugs: The Number of New Drugs Marketed in 2017 Set a New Record for Recent 20 Years
Dophine
January 03, 2018
FDA approved the marketing of 46 new drugs in total by December 21, 2017, successfully setting a new review record for the recent 20 years.